|
× |
 |
Safety and Tolerability of Aripiprazole for Irritability in Pediatric Patients With Autistic Disorder: A 52-Week, Open-Label, Multicenter Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Third Generation Anticonvulsants in Bipolar Disorder: A Review of Efficacy and Summary of Clinical Recommendations PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prevalence, Correlates, Disability, and Comorbidity of DSM-IV Narcissistic Personality Disorder: Results From the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Open-Label Study of Citalopram in Body Dysmorphic Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Analysis of Relapse Rates and Predictors of Relapse in 2 Randomized, Placebo-Controlled Trials of Desvenlafaxine for Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Prediction of Suicidal Behavior in Clinical Research by Lifetime Suicidal Ideation and Behavior Ascertained by the Electronic Columbia-Suicide Severity Rating Scale PDF |
$40.00 |
|
$40.00 |
|
× |
|
Rapid and Sustained Resolution of Misophonia-Type Hyperacusis With the Selective Serotonin Reuptake Inhibitor Sertraline PDF |
$40.00 |
|
$40.00 |
|
× |
|
An Open Trial of Adjunctive Escitalopram in Bipolar Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
The New Hampshire Hospital Screening and Referral Algorithm (NHHSRA) for Substance Use in People With Serious Mental Illness PDF |
$40.00 |
|
$40.00 |
|
× |
|
Substitution of an SSRI With Bupropion Sustained Release Following SSRI-Induced Sexual Dysfunction PDF |
$40.00 |
|
$40.00 |
|
× |
|
Coping With Craving and Withdrawal Due to Substance Use Disorders During the COVID-19 Lockdown PDF |
$40.00 |
|
$40.00 |
|
× |
|
Stabilization of Mood From Below Versus Above Baseline in Bipolar Disorder: A New Nomenclature PDF |
$40.00 |
|
$40.00 |
|
|
